Maintenance Therapy in NSCLC Program by Dr. Mark Socinski, now available as Podcast


I’m very pleased to offer the podcast materials for the recent webinar by Dr. Mark Socinski, medical oncologist and leader of the excellent Thoracic Oncology Program at the University of North Carolina, in Chapel Hill.  He’s been a long-time leader of the entire field of lung cancer for many years, and he’s among the best at synthesizing new information into a cogent perspective.

Here is the audio and video versions of the podcast, along with the figures and transcript that go with the program.

socinski-maintenance-therapy-webinar-audio-podcast

socinski-maintenance-therapy-webinar-figures

socinski-maintenance-therapy-webinar-transcript

The question and answer session will follow as a separate podcast.

Finally, I’ll mention that this webinar and podcast was made possible through an educational grant from Lilly Oncology, who had no input in the development of its content.  We thank them for their support.

Related posts:

    Podcast of Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors A few weeks ago, Dr. Lecia Sequist, Assistant Professor of Medicine at Harvard Medica...

    ASCO Highlights in Advanced NSCLC, by Dr. Nasser Hanna Here’s the second talk from our recent webinar, partnering with LUNGevit...

    First ASCO Highlights Podcast: Dr. Pinder on Small Cell, Early Stage NSCLC, and Mesothelioma Several weeks ago, we were fortunate enough to have Dr. Mary Pinder (alternatel...

    Podcast on Tobacco, Smoking Patterns, and the Association with Lung Cancer Several weeks ago we did a webinar, co-sponsored with LUNGevity Foundation, wit...

    Challenging Cases in Lung Cancer Podcast Series: Adjuvant Chemo for a Small NSCLC Tumor with a Satellite Lesion This is the first of a series of podcasts we’ve done, developed in partnershi...

Posted in: Chemotherapy, First-line treatment, GRACEcast, Lung Cancer, Metastatic/Recurrent NSCLC, First Line, Metastatic/Recurrent NSCLC, Second Line and Later, Non-Small Cell Lung Cancer (NSCLC), Second-line treatment, Stage IV/Advanced/Metastatic NSCLC, Targeted therapies, Treatment, Webinars

2 Comments  

mikem
Posted on April 9, 2010 at 6:43 am

Reaaly really interesting to me since I am on maintenance Alimta. Mine is more of a continuation therapy though since it was my first line and we dropped the platinum after six treatments and significant response. I have already had 3 Alimta only treatments (where does the time go?) and after 3 more we will do another scan to see what is happening. All I can say for now is I feel great and I hope to get many more months out of the Alimta. Not sure my doctor is as confident about the many more, and looking at the stats I understand why but obviously I am going to shoot for as long as I can on a drug that has so far done very well by me. Thank you so much for this informative presentation. –mikem


Lung Cancer FAQ: I’m coming to the end of my first line chemo for advanced NSCLC. After 4 (or 6) cycles are done, should I take a break or continue with some form of maintenance therapy? | GRACE :: Lung Cancer
Posted on September 26, 2010 at 5:14 pm

[...] Podcast on maintenance therapy concepts and evidence [...]